Studies of the inactivation of human placentae aromatase by 17α-ethynyl-substituted 10β-hydroperoxy and related 19-nor steroids

Douglas F. Covey, William F. Hood, Patrick C. McMullan

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

The inactivation of human placental aromatase by 17α-ethynyl-10β-hydroperoxy-17β-hydroxy -4-estren-3-one (SCH 10015) was investigated. In either the presence or absence of added NADPH, SCH 10015 (Ki = 41 μM) caused a time-dependent loss of aromatase activity (e.g. 50% loss after 20 min with 20 μM SCH 10015). Evidence for the oxidation of an active site sulfhydryl group as the molecular basis for SCH 10015 inactivation is presented. The contraceptive 17α-ethynyl-substituted 19-nor steroids, norethisterone (Ki = 48 μM) and norethynodrel (Ki = 38 μM), were evaluated and found not to inactivate aromatase, suggesting that the potential conversion of either compound to SCH 10015 did not occur to a significant extent in these microsomal incubations. It is speculated that the previously observed potent contraceptive effects of SCH 10015 may have been the result of irreversible inhibition of estrogen biosynthesis.

Original languageEnglish
Pages (from-to)1671-1674
Number of pages4
JournalBiochemical Pharmacology
Volume35
Issue number10
DOIs
StatePublished - May 15 1986

Fingerprint Dive into the research topics of 'Studies of the inactivation of human placentae aromatase by 17α-ethynyl-substituted 10β-hydroperoxy and related 19-nor steroids'. Together they form a unique fingerprint.

  • Cite this